New Laboratory
Transpharmation announces the opening of a new laboratory in Poland. “We see Poland rising within the biotechnology and drug-discovery sector, with pharmaceutical companies moving and expanding to develop new technologies and focus on novel treatments to tackle neurodegenerative, neuropsychiatric and neurodevelopmental diseases which affect us all,” reveals Mark Duxon CEO. This news comes not long after Transpharmation revealed the launch of additional laboratory space at Discovery Park, Kent, boosting its growing list of facilities and opening up further opportunities to expand its preclinical services.